Literature DB >> 456294

The treatment of metabolic bone disease.

S Posen, P Clifton-Bligh, R S Mason.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 456294     DOI: 10.2165/00003495-197917040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  11 in total

1.  Osteoclast ultrastructure in Paget's disease.

Authors:  A Rebel; K Malkani; M Baslé; C Bregeon
Journal:  Calcif Tissue Res       Date:  1976-04-20

2.  Effect of estrogens and calcium carbonate on bone loss in postmenopausal women.

Authors:  R R Recker; P D Saville; R P Heaney
Journal:  Ann Intern Med       Date:  1977-12       Impact factor: 25.391

3.  The relevance of 25-hydroxycalciferol measurements in sera of patients with renal failure.

Authors:  R S Mason; D Moddel; A McElduff; J H Stewart; J F Mahony; S Posen
Journal:  Aust N Z J Med       Date:  1979-06

4.  A cheap oral therapy for Paget's disease of bone.

Authors:  R A Evans
Journal:  Calcif Tissue Res       Date:  1977-05

5.  Osteoporosis: diagnosis and treatment.

Authors:  J Ingham
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Geographic variation in the prevalence of Paget's disease of bone.

Authors:  H D Rosenbaum; D J Hanson
Journal:  Radiology       Date:  1969-04       Impact factor: 11.105

7.  Transient hyperphosphatasemia of infancy--an insufficiently recognized syndrome.

Authors:  S Posen; C Lee; R Vines; H Kilham; S Latham; J F Keefe
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

8.  Preventive effect of estrogen on postmenopausal bone loss.

Authors:  S Meema; M L Bunker; H E Meema
Journal:  Arch Intern Med       Date:  1975-11

9.  The relevance of 25-hydroxycalciferol measurements in the treatment of hypoparathyroidism.

Authors:  R S Mason; S Posen
Journal:  Clin Endocrinol (Oxf)       Date:  1979-03       Impact factor: 3.478

10.  Some problems associated with assay of 25-hydroxycalciferol in human serum.

Authors:  R S Mason; S Posen
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.